Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 38

1.

Outer retinal circular structures in patients with Bietti crystalline retinopathy.

Kojima H, Otani A, Ogino K, Nakagawa S, Makiyama Y, Kurimoto M, Guo C, Yoshimura N.

Br J Ophthalmol. 2012 Mar;96(3):390-3. doi: 10.1136/bjo.2010.199356. Epub 2011 Jul 29.

2.

Bietti crystalline retinal dystrophy with subfoveal neurosensory detachment and congenital tortuosity of retinal vessels: case report.

Padhi TR, Kesarwani S, Jalali S.

Doc Ophthalmol. 2011 Jun;122(3):199-206. doi: 10.1007/s10633-011-9274-1. Epub 2011 May 25.

PMID:
21611771
3.

Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy.

Xiao X, Mai G, Li S, Guo X, Zhang Q.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):181-6. doi: 10.1016/j.bbrc.2011.04.112. Epub 2011 May 1.

PMID:
21565171
4.

An atypical form of Bietti crystalline dystrophy.

Rossi S, Testa F, Li A, Iorio VD, Zhang J, Gesualdo C, Corte MD, Chan CC, Fielding Hejtmancik J, Simonelli F.

Ophthalmic Genet. 2011 Jun;32(2):118-21. doi: 10.3109/13816810.2011.559653. Epub 2011 Mar 8.

5.

New gene variants associated with venous thrombosis: a replication study in White and Black Americans.

Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, Hooper WC.

J Thromb Haemost. 2011 Mar;9(3):489-95. doi: 10.1111/j.1538-7836.2011.04185.x.

6.

Bietti crystalline dystrophy and choroidal neovascularisation.

Gupta B, Parvizi S, Mohamed MD.

Int Ophthalmol. 2011 Feb;31(1):59-61. doi: 10.1007/s10792-010-9406-8. Epub 2010 Oct 23.

PMID:
20972604
7.

High-resolution optical coherence tomography shows new aspects of Bietti crystalline retinopathy.

Pennesi ME, Weleber RG.

Retina. 2010 Mar;30(3):531-2. doi: 10.1097/IAE.0b013e3181c96a15. No abstract available.

PMID:
20139800
8.

Outer retinal tubulation: a novel optical coherence tomography finding.

Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB.

Arch Ophthalmol. 2009 Dec;127(12):1596-602. doi: 10.1001/archophthalmol.2009.326. Erratum in: Arch Ophthalmol. 2012 Jul 1;130(7):856.

PMID:
20008714
9.

Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes.

Lai TY, Chu KO, Chan KP, Ng TK, Yam GH, Lam DS, Pang CP.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1092-7. doi: 10.1167/iovs.09-3665. Epub 2009 Sep 24.

PMID:
19797200
10.

Posterior scleral reinforcement in the treatment of macular retinoschisis in highly myopic patients.

Zhu Z, Ji X, Zhang J, Ke G.

Clin Exp Ophthalmol. 2009 Sep;37(7):660-3. doi: 10.1111/j.1442-9071.2009.02111.x.

PMID:
19788661
11.

Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase.

Nakano M, Kelly EJ, Rettie AE.

Drug Metab Dispos. 2009 Nov;37(11):2119-22. doi: 10.1124/dmd.109.028530. Epub 2009 Aug 6.

12.

Genetic variants associated with deep vein thrombosis: the F11 locus.

Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR.

J Thromb Haemost. 2009 Nov;7(11):1802-8. doi: 10.1111/j.1538-7836.2009.03544.x. Epub 2009 Jul 6.

13.

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.

Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE.

Blood. 2009 May 21;113(21):5298-303. doi: 10.1182/blood-2008-11-190389. Epub 2009 Mar 10.

14.

Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.

Hardwick JP.

Biochem Pharmacol. 2008 Jun 15;75(12):2263-75. doi: 10.1016/j.bcp.2008.03.004. Epub 2008 Mar 15.

PMID:
18433732
15.

Novel CYP4V2 gene mutation in a Mexican patient with Bietti's crystalline corneoretinal dystrophy.

Zenteno JC, Ayala-Ramirez R, Graue-Wiechers F.

Curr Eye Res. 2008 Apr;33(4):313-8. doi: 10.1080/02713680801983217.

PMID:
18398705
16.

Gene variants associated with deep vein thrombosis.

Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR.

JAMA. 2008 Mar 19;299(11):1306-14. doi: 10.1001/jama.299.11.1306.

PMID:
18349091
17.

Functional and clinical findings in 3 female siblings with crystalline retinopathy.

Chen H, Zhang M, Huang S, Wu D.

Doc Ophthalmol. 2008 May;116(3):237-43. Epub 2007 Oct 26.

PMID:
17962988
18.

Genotype phenotype analysis of Bietti's crystalline dystrophy in patients with CYP4V2 mutations.

Lai TY, Ng TK, Tam PO, Yam GH, Ngai JW, Chan WM, Liu DT, Lam DS, Pang CP.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5212-20.

PMID:
17962476
19.

Long-term follow-up in Bietti crystalline dystrophy.

Mansour AM, Uwaydat SH, Chan CC.

Eur J Ophthalmol. 2007 Jul-Aug;17(4):680-2.

20.

Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations.

Nakamura M, Lin J, Nishiguchi K, Kondo M, Sugita J, Miyake Y.

Adv Exp Med Biol. 2006;572:49-53.

PMID:
17249554

Supplemental Content

Support Center